ILA
ISLAND PHARMA ORDINARYIsland Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company's lead product candidate is ISLA-101, a drug which is in second clinical-stage for the prevention and treatment of dengue fever and other mosquito vector borne diseases; and Galidesivir, a spectrum antiviral candidate with the potential to address multiple high-priority RNA virus threats. Island Pharmaceuticals Limited was founded in 2017 and is based in Hawthorn East, Australia.
ILA
ILA
ISLAND PHARMA ORDINARY
Island Pharmaceuticals Limited, a drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States. The company's lead product candidate is ISLA-101, a drug which is in second clinical-stage for the prevention and treatment of dengue fever and other mosquito vector borne diseases; and Galidesivir, a spectrum antiviral candidate with the potential to address multiple high-priority RNA virus threats.
Fundamentals
Historical Data14 days
| Date | Short % | Gross Short |
|---|---|---|
| 28 Aug | — | — |
| 27 Aug | — | — |
| 26 Aug | — | — |
| 25 Aug | 0.00% | — |
| 24 Aug | 0.00% | — |
| 21 Aug | 0.00% | — |
| 20 Aug | 0.00% | — |
| 19 Aug | 0.00% | — |
| 18 Aug | 0.00% | — |
| 17 Aug | 0.00% | — |
| 14 Aug | 0.00% | — |
| 13 Aug | 0.00% | — |
Island Pharma (ILA) Short Interest Summary
Island Pharma (ILA) currently has 0.00% of its shares sold short (2 thousand shares, worth approximately $1K), based on ASIC short position data reported on 25 August 2026 (T+4 reporting lag). That makes ILA the #648 most shorted stock on the ASX most shorted list. Short interest in ILA is up 0.00% over the past week. ILA is part of the Health Care sector on the ASX.
Recent ILA Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 25 Aug 2026 | 0.00% | 0.0M | $0.47 |
| 24 Aug 2026 | 0.00% | 0.0M | $0.47 |
| 21 Aug 2026 | 0.00% | 0.0M | $0.49 |
| 20 Aug 2026 | 0.00% | 0.0M | $0.46 |
| 19 Aug 2026 | 0.00% | 0.0M | $0.45 |
| 18 Aug 2026 | 0.00% | 0.0M | $0.46 |
| 17 Aug 2026 | 0.00% | 0.0M | $0.43 |
| 14 Aug 2026 | 0.00% | 0.0M | $0.44 |
| 13 Aug 2026 | 0.00% | 0.0M | $0.46 |
| 12 Aug 2026 | 0.00% | 0.0M | $0.46 |
ILA Short Selling — Frequently Asked Questions
What is Island Pharma (ILA)'s current short interest?
Island Pharma (ILA) currently has a short interest of 0.00% of total shares outstanding. This means 0.00% of ILA's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is ILA heavily shorted on the ASX?
ILA has a relatively low short interest of 0.00%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for ILA investors?
Short interest in ILA shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.00%, ILA's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this ILA short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for ILA.